Reserach & Innovation
Built on Science. Validated in Clinical Practice.
CardiaMetrics combines clinical research, hospital collaborations, and a robust patent portfolio to predict cardiac decompensation earlier and improve patient outcomes.
Grounded in Science. Protected by Innovation.
CardiaMetrics builds on advanced cardiovascular monitoring R&D and protected technology, providing a strong foundation of innovation and defensibility for our predictive cardiac insights.
Published Research & Scientific Recognition
Clinical Study in Progress
We’ve partnered with CHU de Caen Normandie to conduct our first clinical study, focused on collecting cardiac signals essential for refining our predictive AI models. This study marks a major validation milestone in real-world cardiac telemonitoring and will inform future algorithm enhancements.
More Studies Underway
Two additional clinical studies are in planning stages, expanding evidence generation across diverse patient populations and clinical scenarios.
Scientific Presence at Key Conferences
Our first research findings were presented at Technology and Heart Failure Therapeutics (THT), with further insights shared at cardiology innovation events, reflecting growing scientific engagement and thought leadership.
CardiaMetrics Presents Its First Scientific Results at Technology and Heart Failure Therapeutics in Boston
CardiaMetrics is proud to announce that our first scientific results will be presented at Technology and Heart Failure Therapeutics (THT) in Boston (Home Page | THT 2026), one of the world’s leading conferences dedicated to breakthrough technologies in heart failure...
Strategic Academic Collaborations
Our research ecosystem is strengthened by deep collaborations with top clinical research centers:
CHU de Caen Normandie
Ongoing clinical study and technology evaluation partnership.
unicaen
UE
CHU Caen Normandie
inserm
Université Grenoble Alpes
This collaborative network ensures our platform is scientifically validated and clinically relevant.
Our Patent Portfolio
CardiaMetrics has acquired a portfolio of patents and patent applications originally developed by Sentinhealth, covering innovations in cardiac monitoring technology. This portfolio strengthens our technology moat and supports long-term product differentiation.
Device for Determining Cardiac Decompensation Information
Summary:
A device designed to analyze cardiac parameters and detect early indicators of heart failure decompensation through continuous physiological signal measurement.
US20220273223A1 – Publish Sep 1st, 2022
Signal Processing Method for Determining a Respiratory Parameter
Summary:
Advanced processing of accelerometric and ECG signals to derive respiratory parameters, supporting multi-physiological monitoring for heart failure patients.
FR3150944A1 – Jan 17th, 2025
Method for Determining a Patient’s Risk of Cardiac Decompensation
Summary:
A predictive method using accelerometric signal processing to assess and quantify heart failure decompensation risk before acute events occur.
FR3144911A1 – Dec 18th, 2023
Subcutaneous Implant and Mounting Method
Summary:
A subcutaneous implant architecture enabling long-term physiological monitoring and communication, supporting next-generation cardiac telemetry.
FR3149766A1 – Dec 20th, 2024
System for Monitoring Heart Failure Decompensation Using a Subcutaneous Implant
Summary:
A complete monitoring system combining implantable sensing and predictive analytics to detect heart failure deterioration early.
FR3145267A1 – Aug 2nd, 2024